In this post I link to and excerpt from the 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines [PubMed Abstract] [Full Text HTML] [Full Text PDF]. Circulation. 2021 Feb 2;143(5):e35-e71. doi: 10.1161/CIR.0000000000000932. Epub 2020 Dec 17.
The above is an awesome resource and is 156 pp [PDF].
Using the HTML copy, you can quickly go to any section of the document:
Jump to
- Table of Contents
- Top 10 Take-Home Messages
- Preamble
- 1. Introduction
- 2. General Principles
- 3. Aortic Stenosis
- 4. Aortic Regurgitation
- 5. Bicuspid Aortic Valve
- 6. Mitral Stenosis
- 7. Mitral Regurgitation
- 8. Tricuspid Valve Disease
- 9. Pulmonic Valve Disease
- 10. Mixed Valve Disease
- 11. Prosthetic Valves
- 12. Infective Endocarditis
Here are the excerpts:
Synopsis
The value of the MDT [Multidisciplinary Team] has become increasingly apparent as options in the treatment of VHD [Valvular Heart Disease] have broadened. Heart Valve Centers, in the context of an integrated multi-institutional model of care for patients with VHD, allow optimization of patient outcomes through improved decision-making and matching of
patients to providers with appropriate expertise, experience, and resources.12 Primary and Comprehensive Heart Valve Centers are defined by their offerings and expertise in the management of patients with VHD12 (Table 11).
